Current Studies – Actively Recruiting
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
Brief Summary: This study will evaluate the long-term safety and efficacy of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR
studies (192024-091, -092, -093, or -095) and received Bimatoprost SR.
Patients who completed 1 of the 4 Bimatoprost SR Phase 3 studies (192024-091, -092, -093, or -095) and received Bimatoprost SR
-> Female patients who are pregnant, nursing, or planning a pregnancy, or who are of childbearing potential and not using a reliable means of contraception during the study
-> Concurrent or anticipated enrollment in another investigational drug or device study during the present study
-> Any condition which would preclude the patient’s ability to comply with study requirements, including completion of the study
-> Patients who were randomized to receive timolol eye drops in the study eye (control group) during the Phase 3 Bimatoprost Studies 192024-091 and -092
Ophthalmic Research Coordinator
Joanne Guzman is our lead ophthalmic research coordinator. She is dedicated to providing patients with access to cutting-edge treatments through clinical trials. She is known for always putting patients first and focusing on how patients benefit from participating in clinical trials. She was an ophthalmic technician prior to joining us in clinical research. Her previous experience in ophthalmology, her attention to detail and genuine empathy has been instrumental in helping our patients understand clinical trials for eye diseases.
Contact Joanne: 202-239-0777 ext 102
Past (Closed) Studies
Pink Eye (Conjunctivitis) Study
If you do have pink eye, you may be eligible to participate in this research study. Pink eye is an infection of the eye that can cause eye redness, tearing, and eyes feeling sore, gritty, or irritated. Pink eye spreads easily between
people and to the other eye of the same person.
The study will evaluate an investigational drug in the form of eye drops intented to treat pink eye. Both adults and children are eligible to participate.
Volunteers who take part in the study will receive all study-related care and study drug at no cost. Volunteers may also be reimbursed for travel expenses.
No health insurance is required to participate.
To participate you must:
-> Be experiencing signs/symptoms of pink eye for no more than the past 4 days.
-> Be interested in taking part in a research study fot up to 13 days.
-> Be willing to travel to the study center for appointments.
Frequently Asked Questions
Are Clinical Trials Safe?